Last quarter (Q4 2022), Surgical Innovations's total revenue was £―, a decrease of ― from the same quarter last year. In Q4, Surgical Innovations's net income was £―. See Surgical Innovations’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	£ 11.34M	£ 9.13M	£ 6.33M	£ 10.73M	£ 10.97M
Cost of Revenue	-	£ 6.94M	£ -6.00M	£ 5.06M	£ 6.40M	£ 6.30M
Gross Profit	-	£ 4.40M	£ 3.13M	£ 1.27M	£ 4.33M	£ 4.67M
Operating Expense	-	£ 4.33M	£ -3.39M	£ 3.64M	£ 4.33M	£ 4.33M
Operating Income	-	£ 72.00K	£ -257.00K	£ -2.37M	£ -2.00K	£ 347.00K
Net Non Operating Interest Income Expense	-	£ -98.00K	£ 130.00K	£ -137.00K	£ -157.00K	£ -105.00K
Other Income Expense	-	£ -51.00K	-	-	-	-
Pretax Income	-	£ -57.00K	£ -585.00K	£ -3.31M	£ -2.60M	£ 515.00K
Tax Provision	-	£ -321.00K	£ 129.00K	£ -31.00K	£ 23.00K	£ -210.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	£ 264.00K	£ -456.00K	£ -3.28M	£ -2.62M	£ 725.00K
Basic EPS	-	-	-	£ >-0.01	£ >-0.01	£ <0.01
Diluted EPS	-	-	-	£ >-0.01	£ >-0.01	£ <0.01
Basic Average Shares	-	£ 932.82M	£ 936.56M	£ 834.76M	£ 789.85M	£ 782.57M
Diluted Average Shares	-	£ 932.82M	£ 938.78M	£ 836.82M	£ 891.31M	£ 829.58M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	£ >-0.01	£ <0.01	£ <0.01
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	£ 2.00K	£ 42.00K	£ 178.00K
Total Expenses	-	£ 11.27M	£ -9.38M	£ 8.70M	£ 10.73M	£ 10.62M
Net Income From Continuing And Discontinued Operation	-	£ 264.00K	£ -456.00K	£ -3.28M	£ -2.62M	£ 725.00K
Normalized Income	-	£ -378.00K	£ -714.00K	£ -1.35M	£ 979.97K	£ 503.87K
Interest Expense	-	-	-	£ 138.00K	£ 162.00K	£ 105.00K
EBIT	-	£ -8.00K	£ -715.00K	£ -3.17M	£ -2.43M	£ 620.00K
EBITDA	-	£ 579.00K	£ -715.00K	£ -884.00K	£ 1.08M	£ 2.24M

Currency in GBP

Surgical Innovations Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing